Board of Advisors

Hatsuo Aoki

Advisor to the Board,Astellas Pharma Inc.

With a rapidly declining birthrate and aging population and challenges in securing financial sources, the time has come for national debate on health policy in Japan. For more activated debate and ideal results, I hope the Health Policy Institute, Japan will proactively assume the role of providing constructive recommendations.

Keiko Amano

Director, Chiba Prefectural Institute of Public Health

Given rapid technological developments in healthcare, doctors have become obsessed with the acquisition of healthcare technology, thus widening the gap between patients and themselves. Evidence-based medicine is, needless to say, important, but with a declining birthrate and aging population, we are in urgent need of a healthcare system that also recognizes the importance of healthcare responsive to the voices of patients. I look forward to the work of Health Policy Institute, Japan.

Yuichiro Anzai

President, Keio University

”Nation-building is the task of the individual, not the ‘public’” This is a passage from Fukuzawa Yukichi’s “Yasegaman-no-setsu” (Fighting to the Bitter End). Policy recommendations devised from an independent perspective are essential for the resolution of the complex issues faced today and for humanity to enjoy the benefits of medical and bioscientific expertise. Established as a think-tank independent of government, Health Policy Institute, Japan holds great promises for the future.

Matthew Anderson

Group Director, Strategy & Corporate Affairs News Corporation Europe & Asia

Around the world, great strides are being made in the field of health communication and so-called "social marketing" campaigns. I commend the Health Policy Institute, Japan for exploring global best practice that involves all relevant stakeholders in initiatives that not only raise awareness, but also lead to meaningful behavioural change in the lives of patients and citizens at large.

Hisao Endo

Professor, Gakushuin University
Chairman, Central Social Insurance Medical Council (MHLW)

Both a scientific perspective (measurement of the cost-effectiveness of healthcare, etc.) and a perspective to equitably represent the public’s values (how large public healthcare expenditures should be, etc.) are essential in health policy. Both aspects remain at unsatisfactory levels in health policy making procedures today. I strongly hope that the Health Policy Institute, Japan will contribute to the improvement of these aspects of decision-making.

Keiko Okaya

RN., Ph.d. Dean, Professor, School of Nursing, University of KinDAI Himeji

According to a survey conducted by the National Institute of Longevity Sciences, across all age groups, the percentage of Japanese feeling insecure about aging was over 80%. I commend the Health Policy Institute, Japan to be an academic institution presenting tangible and effective policy recommendations to reestablish the social security system so that the Japanese public will be freed of their fears and be able to live in a sense of reassurance regardless of their health conditions,

Hisashi Katsumura

Member, Central Social Insurance Medical Council (MHLW)
Member, Patient Advocacy Group
Member, Japan Council for Quality Health Care

The current health insurance system is on the brink of disintegration before it has even been able to reform its emergency medical care program or standardize care delivery; thus, benevolent doctors are suffering from overwork. We are in need of a health policy that is clearly different from the conventional policy, which has evolved indifferent of lessons learned and in the absence of the public and patients.

Hiroshi Kato

President Emeritus, Chiba University of Commerce
Professor Emeritus, Keio University

Faced with an aged society with a declining birthrate, Japan’s health policy has become more chaotic than ever. The voices of doctors, nurses, patients and hospitals have been heard but remain mutually incompatible; we can have a secure health policy only when these opinions have reached a consensus.

Kakutaro Kitashiro

Senior Advisor, IBM Japan, Ltd.

In a society where rejuvenation is a pressing issue, healthcare is an area with promises of major innovations led by the private sector. I commend the Institution to integrate the sagacity of disparate fields to make visionary health policy recommendations.

Hiroshi Komiyama

President, The University of Tokyo

Health care will develop into a large market not only encompassing engineering, physics and pharmaceutical science, but will also have strong links with other fields including law and economy. I look forward to the Health Policy Institute, Japan’s contribution to innovative developments in the once untouchable healthcare field.

Takeshi Sasaki

Professor, Gakushuin University

As a channel for voices that have not been sufficiently represented in health policy, Health Policy Institute, Japan is looked upon with great expectations, for which it bears immense responsibilities.

Haruo Shimada

President, Chiba University of Commerce

Health is a priority concern of the public in Japan, where society is rapidly aging.Health promotion entails many issues, including the improvement of lifestyle, to be addressed by individuals and society; the most urgent being whether or not each citizen can receive the appropriate healthcare service. Japan’s healthcare technology and knowledge are at the highest global standards in many fields, but there are many issues yet to be solved regarding healthcare services. Assessment data regarding the qualifications and performance of medical institutions and doctors for serious diseases, including cancer, cardiovascular disorder and organ dysfunction, in particular, are insufficient or unevenly distributed; thus many people are gnawed by anxiety, unsure whether they can receive the appropriate healthcare, how and from whom. The Health Policy Institute, Japan seeks to resolve these issues by focusing on the analysis, assessment, compilation and provision of sufficient data and to develop a healthcare service framework suitable for a developed country. I ask for the kind understanding and support of a broad audience for the Institute’s involvement in such issues.

Ryozo Nagai

Professor and Chairman, Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo

Today, we are faced with a host of healthcare-related issues. I believe the Health Policy Institute, Japan should play a potent role in determining health policy under social consensus.

Osamu Nagayama

President and CEO, Chugai Pharmaceutical. Co., Ltd

Given the significant developments in the life sciences and an increasing number of health conscious people, healthcare services compatible with the perspectives and needs of patients are called for. On the other hand, entering an era of aging society with few children and low economic growth, the appropriate management of aggrandizing healthcare expenditures has become the priority issue in relation with the sustainability of society.

Shuzo Nishimura

Exective Vice President, Kyoto University

It is often believed that healthcare-related decision-making requires specialized knowledge; thus, policy formation has tended to involve only specialists, such as doctors. However, I believe that it is extremely important for patients and the public to participate in policy-making.

Taizo Nishimuro

Advisor to the Board, Toshiba Corporation
President & CEO, Tokyo Stock Exchange, Inc.

I have great expectations for the Health Policy Institute, Japan: gaining a clear view of the status quo of Japanese healthcare in a global context and exhibiting an ideal framework for the welfare of the future public.

Hiroshi Yoshikawa

Professor, The University of Tokyo

In order to maintain an insurance system covering all citizens, we must continue in constructive debate from a wide perspective; I hope the Health Policy Institute, Japan will assume a leading role.

back to the top